MedTrace Logo

Protons Vs. Photons for High-risk Prostate Cancer

NCT05350475 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2025-03-07

No results posted yet for this study

Summary

The purpose of this study is to assess late gastro-intestinal side-effects comparing proton therapy to photon therapy in high-risk prostate cancer patients receiving whole pelvic irradiation.

Conditions

Interventions

RADIATION

Proton therapy

Patients in the experimental arm will receive proton therapy within the same dose and fraction schedule as patients receiving photon therapy, which is standard treatment.

RADIATION

Photon therapy

Patients in the photon arm will receive standard treatment with photon therapy.

Sponsors & Collaborators

  • Rigshospitalet, Denmark

    collaborator OTHER

  • Odense University Hospital

    collaborator OTHER

  • Aarhus University Hospital

    collaborator OTHER

  • Aalborg University Hospital

    collaborator OTHER

  • Sygehus Lillebaelt

    collaborator OTHER

  • Herlev and Gentofte Hospital

    collaborator OTHER

  • Naestved Hospital

    collaborator OTHER

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Stine Elleberg Petersen, MD, Ph.D · Danish Centre for Particle Therapy, Aarhus University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-01
Primary Completion
2027-03-01
Completion
2037-03-01

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05350475 on ClinicalTrials.gov